Bioclinic Naturals
Bioclinic Naturals Urinary-Pro 60 Tablets
- SKU:
- 23460
- UPC:
- 629022091324
- MPN:
- BCN-9807
- Maximum Purchase:
- 1 unit
Description
Bioclinic Naturals Urinary-Pro 60 Tablets :
Contains a unique combination of four plant extracts that promote healthy urinary function; Provides bearberry (uva-ursi) standardized to 20% of arbutin, with both diuretic and antimicrobial actions; Berberine hydrochloride enhances Nrf2 activity, promoting anti-inflammatory and antioxidant effects; Juniper and berberine extracts both inhibit bacterial adhesion and biofilm formation; Echinacea purpurea enhances immune function and provides antiviral support.
Ingredients:
Each Tablet Contains: | |
Bearberry Extract (Arctostaphylos uva-ursi) (leaf) (20% arbutin) | 250 mg |
Berberine (hydrochloride) | 50 mg |
Juniper Extract 4:1 (Juniperus communis) (fruit) | 37.1 mg |
Organic Echinacea Extract 6:1 (Echinacea purpurea) (herb top) | 50 mg |
Non-Medicinal Ingredients: Microcrystalline cellulose, dibasic calcium phosphate dihydrate, croscarmellose sodium, coating (carbohydrate gum, glycerin), silica, stearic acid, vegetable grade magnesium stearate (lubricant).
Allergens & Purity: Contains no artificial colours, preservatives, or sweeteners; no dairy, starch, sugar, wheat, gluten, yeast, soy, egg, fish, shellfish, animal products, tree nuts, or GMOs. Suitable for vegetarians/ vegans. Sealed for your protection. Do not use if seal is broken. For freshness, store in a cool, dry place.www.healthpalace.ca
Recommended Dose: 2 tablets 2 times per day or as directed by a health care practitioner. Take a few hours before or after any medical agents or natural health product. Do not take with highly acidic foods (e.g., citrus fruits and juice) or medical agents, which may acidify urine. For occasional use only. Consult a health care practitioner for use beyond one week.
Cautions: No known interactions exist. As a diuretic, bearberry theoretically may increase serum lithium levels, but this has not been shown clinically. Berberine has been shown to lower blood glucose levels and may have an additive effect when combined with other hypoglycemic agents. Berberine has also been shown to increase levels of cyclosporin A, and combined use should be avoided. Berberine has demonstrated inhibitory activity on cytochrome enzymes CYP2D6, CYP3A4, and CYP2C9, and use of agents metabolized by these enzymes should be monitored. Echinacea has been shown to reduce the required immune inhibitory agents dosage in inflammatory conditions, and may improve the efficacy of antifungal treatments for infection with Candida sp.16,17,18 Although direct evidence of interactions with echinacea is lacking, it is a weak inhibitor of CYP1A2 and a minor inducer of CYP3A4, and may have a slight effect on agents metabolized through these pathways.